Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 07, 2026 09:18 ET | Source: NurExone Biologic Inc

NurExone Biologic’s U.S. Subsidiary Exo-Top and Florida-Based BioXtek Sign Strategic LOI for Exosome Manufacturing and Commercialization

TORONTO, Ontario and HAIFA, Israel and POMPANO BEACH, Florida, April 07, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) and...
April 07, 2026 09:00 ET | Source: EnWave Corporation

EnWave Signs Research and Development License Agreement with Rhizome Food and Farming LLC, a Food Innovation Company Led by Michelin-Starred Chef Dan Barber

VANCOUVER, British Columbia, April 07, 2026 (GLOBE NEWSWIRE) -- EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") announced today that it has signed a Research and Development...
April 07, 2026 08:00 ET | Source: Sonoro Gold Corp.

SONORO GOLD ANNOUNCES FULLY-COMMITTED $11 MILLION PRIVATE PLACEMENT & 50,000 METER DRILLING PROGRAM

VANCOUVER, Canada, April 07, 2026 (GLOBE NEWSWIRE) -- Sonoro Gold Corp. (TSXV: SGO | OTCQB: SMOFF | FRA: 23SP) (“Sonoro” or the “Company”) is pleased to announce a fully-committed non-brokered...
April 07, 2026 08:00 ET | Source: NowVertical Group Inc

NowVertical Expands Strategic Engagement with Global Information Services Company, Surpassing $2.8M Signed in First Year

TORONTO, April 07, 2026 (GLOBE NEWSWIRE) -- NowVertical Group Inc. (TSXV: NOW) (“NowVertical” or the “Company”), a data and AI solutions and services provider, today announced the scale up of its...
April 07, 2026 07:30 ET | Source: NervGen Pharma Corp.

NervGen Pharma Announces Successful End-of-Phase 2 Meeting and FDA Alignment on RESTORE, a Phase 3 Registrational Study of NVG-291 for Chronic Tetraplegia

Alignment with the FDA across proposed study parameters of RESTORE, a 16-week registrational study evaluating NVG-291 in chronic tetraplegia.Primary endpoint will be the change from baseline in GRASSP...
April 07, 2026 07:30 ET | Source: Marvel Biosciences Corp.

Marvel Biosciences Secures Financial and Strategic Investment with 5 Horizon Ventures

Marvel announces financial and strategic backing from 5 Horizons Ventures to support its upcoming Phase 1 clinical trial of patented lead asset MB-204
April 07, 2026 07:00 ET | Source: Ressources HPQ Silicium inc.

Les cellules 21700 GEN4 de HPQ atteignent 6 696 mAh, parmi les plus fortes capacités rapportées mondialement pour les batteries lithium-ion

Les cellules 21700 GEN4 atteignent une capacité moyenne supérieure à 6 600 mAh, avec une cellule record à 6 696 mAh — parmi les plus fortes capacités rapportées mondialement dans ce format [1].Densité...
April 07, 2026 07:00 ET | Source: HPQ Silicon Inc.

HPQ Silicon Reports 6,696 mAh GEN4 21700 Cell Performance Among the Highest Reported Globally

HPQ achieves 6,696 mAh in GEN4 21700 cells, confirming top-tier performance and advancing its silicon-based battery technology roadmap.
April 07, 2026 07:00 ET | Source: Emerita Resources Corp.

Emerita Announces Results of Airborne Electromagnetic and Magnetic Survey, Provides Update on Mineral Resources Estimate

TORONTO, April 07, 2026 (GLOBE NEWSWIRE) -- Emerita Resources Corp. (TSX-V: EMO; OTCQX: EMOTF; FSE: LLJA) (the “Company” or “Emerita”) has received the interpreted results from Helicopter...
April 07, 2026 06:30 ET | Source: Kraken Robotics Inc.

Kraken Robotics Demonstrates KATFISH Autonomous Launch and Recovery from SEFINE USV

ST. JOHN'S, Newfoundland and Labrador, April 07, 2026 (GLOBE NEWSWIRE) -- Kraken Robotics Inc. (“Kraken” or the “Company”) (TSX-V: PNG, OTCQB: KRKNF) announces the successful integration and...